Article
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.
PloS one - 1 Jan 2016
Ochoa Eguzkine, Iriondo Mikel, Manzano Carmen, Fullaondo Asier, Villar Irama, Ruiz-Irastorza Guillermo, Zubiaga Ana M, Estonba Andone
Abstract excerpt
INTRODUCTION: The identification of the genetic risk factors that could discriminate non- thrombotic from thrombotic antiphospholipid antibodies (aPLA) carriers will improve prognosis of these patients. Several human studies have shown the presence of aPLAs associated with atherosclerotic plaque, which is a known risk factor for thrombosis. Hence, in order to determine the implication of atherosclerosis in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
